170 related articles for article (PubMed ID: 37294523)
1. Foveal Eversion is Associated with High Persistence of Macular Edema and Visual Acuity Deterioration in Retinal Vein Occlusion.
Arrigo A; Aragona E; Antropoli A; Bianco L; Rosolia A; Saladino A; Bandello F; Battaglia Parodi M
Ophthalmol Ther; 2023 Aug; 12(4):2157-2169. PubMed ID: 37294523
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Assessment of the Choroidal Vascularity Index in Eyes with Branch Retinal Vein Occlusion-Associated Cystoid Macular Edema.
Pant P; Kundu A; Rathinavelu JK; Wei X; Agrawal R; Stinnett SS; Kim JS; Thomas AS; Fekrat S
Ophthalmol Ther; 2023 Aug; 12(4):2103-2115. PubMed ID: 37221425
[TBL] [Abstract][Full Text] [Related]
3. Collateral Vessel Development in Central and Branch Retinal Vein Occlusions Are Associated With Worse Visual and Anatomic Outcomes.
Arrigo A; Aragona E; Lattanzio R; Scalia G; Bandello F; Parodi MB
Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):1. PubMed ID: 34724540
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of visual prognosis and correlative factors in retinal vein occlusion].
Zhang H; Xia Y
Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):98-102. PubMed ID: 11955310
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up).
Kornhauser T; Schwartz R; Goldstein M; Neudorfer M; Loewenstein A; Barak A
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):835-44. PubMed ID: 26269374
[TBL] [Abstract][Full Text] [Related]
6. Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion.
Ogino K; Tsujikawa A; Murakami T; Muraoka Y; Kurashige Y; Yoshimura N
Clin Ophthalmol; 2011; 5():1031-6. PubMed ID: 21845030
[TBL] [Abstract][Full Text] [Related]
7. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
9. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.
Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Hartnett ME; Cohen G;
Ophthalmology; 2011 Feb; 118(2):345-52. PubMed ID: 20926135
[TBL] [Abstract][Full Text] [Related]
10. Vitrectomy for macular edema due to retinal vein occlusion.
Kumagai K; Ogino N; Fukami M; Furukawa M
Clin Ophthalmol; 2019; 13():969-984. PubMed ID: 31354231
[No Abstract] [Full Text] [Related]
11. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.
Hoeh AE; Ach T; Schaal KB; Scheuerle AF; Dithmar S
Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1635-41. PubMed ID: 19633982
[TBL] [Abstract][Full Text] [Related]
12. SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.
Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Jumper JM; Figueroa M;
Ophthalmology; 2009 Mar; 116(3):504-12. PubMed ID: 19167078
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
[TBL] [Abstract][Full Text] [Related]
15. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.
Papadia M; Misteli M; Jeannin B; Herbort CP
Int Ophthalmol; 2014 Dec; 34(6):1193-201. PubMed ID: 25245600
[TBL] [Abstract][Full Text] [Related]
16. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
[TBL] [Abstract][Full Text] [Related]
17. The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions.
Ivanovska Adjievska B; Boskurt S; Orovcanec N; Dimovska-Jordanova V
Clin Ophthalmol; 2017; 11():1183-1190. PubMed ID: 28790803
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study.
Campochiaro PA; Sophie R; Pearlman J; Brown DM; Boyer DS; Heier JS; Marcus DM; Feiner L; Patel A;
Ophthalmology; 2014 Jan; 121(1):209-219. PubMed ID: 24112944
[TBL] [Abstract][Full Text] [Related]
19. Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema.
Iftikhar M; Mir TA; Hafiz G; Zimmer-Galler I; Scott AW; Solomon SD; Sodhi A; Wenick AS; Meyerle C; Jiramongkolchai K; Liu TYA; Arevalo JF; Singh M; Kherani S; Handa JT; Campochiaro PA
Am J Ophthalmol; 2019 Sep; 205():17-26. PubMed ID: 30954469
[TBL] [Abstract][Full Text] [Related]
20. Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema: Clinical Outcomes in 130 247 Eyes.
Ciulla TA; Hussain RM; Taraborelli D; Pollack JS; Williams DF
Ophthalmol Retina; 2022 Sep; 6(9):796-806. PubMed ID: 35381391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]